Luteinizing Hormone - Releasing Hormone analogue (LHRHa) is a solution that is applied as either an intraperitoneal (IP) or intramuscular (IM) injection. LHRHa is only available for purchase through Syndel USA.

LHRHa is a broad species (low specificity) spawning enhancement peptide. The peptide is intended to provide the ability to synchronize spawns and reduce waiting times and spawn failures.

Luteinizing hormone-releasing hormone (LHRH) agonists and antagonists are commonly used androgen deprivation therapies prescribed for patients with advanced prostate cancer (PCa).

2013年12月1日 · Men with prostate cancer (PCa) frequently undergo androgen deprivation therapy (ADT), typically in the form of a depot injection of luteinizing hormone-releasing hormone agonists (LHRHa).

Temporary OFS, using LHRHa, during adjuvant chemotherapy has been developed as a potential option to prevent chemotherapy-mediated gonadotoxicity and premature ovarian failure (POF) to maintain fertility in women of childbearing age undergoing breast cancer treatment.

Men with prostate cancer (PCa) frequently undergo androgen deprivation therapy (ADT), typically in the form of a depot injection of luteinizing hormone-releasing hormone agonists (LHRHa). LHRHa are associated with many adverse effects (eg, hot flashes, sexual dysfunction, loss of muscle mass, osteop …

LHRHa Liquid is formulated to provide a sterile, liquid injectable in a multi-use container. LHRHa Liquid is available at a concentration of 80ug LHRHa per mL solution in 100ml/vials. (80 ug/ml X 100 ml = 8 mg/vial)

LHRHa is a broad species (low specificity) spawning enhancement peptide. The peptide is intended to provide the ability to synchronize spawns and reduce waiting times and spawn failures.

LHRHa is a broad species (low specificity) spawning enhancement peptide. The peptide is intended to provide the ... The dose calculated based on the weight of the fish. A general dose of LHRHa is 10-20 μg per kilogram of bodyweight. This dose may vary among finfish species and locations. Males may require a ...

Leuprorelin is a type of hormone therapy known as a LHRH (luteinising hormone-releasing hormone) agonist. It is also known as Prostap or Staladex. It is used in the treatment of prostate cancer and breast cancer. How does leuprorelin work? Leuprorelin lowers the level of testosterone made by the testicles.